BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 24927053)

  • 21. Design, diversity-oriented synthesis and structure activity relationship studies of quinolinyl heterocycles as antimycobacterial agents.
    Rachakonda V; Alla M; Kotipalli SS; Ummani R
    Eur J Med Chem; 2013; 70():536-47. PubMed ID: 24189497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salicylanilide diethyl phosphates: synthesis, antimicrobial activity and cytotoxicity.
    Vinšová J; Kozic J; Krátký M; Stolaříková J; Mandíková J; Trejtnar F; Buchta V
    Bioorg Med Chem; 2014 Jan; 22(2):728-37. PubMed ID: 24369840
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and in vitro antimycobacterial activity of 2-methoxybenzanilides and their thioxo analogues.
    Kozic J; Novotná E; Volková M; Stolaříková J; Trejtnar F; Vinšová J
    Eur J Med Chem; 2012 Oct; 56():387-95. PubMed ID: 22907036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Design, synthesis and evaluation of 6-(4-((substituted-1H-1,2,3-triazol-4-yl)methyl)piperazin-1-yl)phenanthridine analogues as antimycobacterial agents.
    Nagesh HN; Naidu KM; Rao DH; Sridevi JP; Sriram D; Yogeeswari P; Chandra Sekhar KV
    Bioorg Med Chem Lett; 2013 Dec; 23(24):6805-10. PubMed ID: 24169232
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of alkynylated 1,2,4-oxadiazole/1,2,3-1H-triazole glycoconjugates: Discovering new compounds for use in chemotherapy against lung carcinoma and Mycobacterium tuberculosis.
    Melo de Oliveira VN; Flávia do Amaral Moura C; Peixoto ADS; Gonçalves Ferreira VP; Araújo HM; Lapa Montenegro Pimentel LM; Pessoa CDÓ; Nicolete R; Versiani Dos Anjos J; Sharma PP; Rathi B; Pena LJ; Rollin P; Tatibouët A; Nascimento de Oliveira R
    Eur J Med Chem; 2021 Aug; 220():113472. PubMed ID: 33940463
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fluorinated 1,2,4-Triazolo[1,5-a]pyrimidine-6-carboxylic acid derivatives as antimycobacterial agents.
    Abdel-Rahman HM; El-Koussi NA; Hassan HY
    Arch Pharm (Weinheim); 2009 Feb; 342(2):94-9. PubMed ID: 19173243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antimycobacterial activity of bisbenzylisoquinoline alkaloids from Tiliacora triandra against multidrug-resistant isolates of Mycobacterium tuberculosis.
    Sureram S; Senadeera SP; Hongmanee P; Mahidol C; Ruchirawat S; Kittakoop P
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2902-5. PubMed ID: 22418278
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting FtsZ for antituberculosis drug discovery: noncytotoxic taxanes as novel antituberculosis agents.
    Huang Q; Kirikae F; Kirikae T; Pepe A; Amin A; Respicio L; Slayden RA; Tonge PJ; Ojima I
    J Med Chem; 2006 Jan; 49(2):463-6. PubMed ID: 16420032
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design, synthesis, and characterization of (1-(4-aryl)- 1H-1,2,3-triazol-4-yl)methyl, substituted phenyl-6-methyl-2-oxo-1,2,3,4-tetrahydropyrimidine-5-carboxylates against Mycobacterium tuberculosis.
    Venugopala KN; Dharma Rao GB; Bhandary S; Pillay M; Chopra D; Aldhubiab BE; Attimarad M; Alwassil OI; Harsha S; Mlisana K
    Drug Des Devel Ther; 2016; 10():2681-90. PubMed ID: 27601885
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and in-vitro antimycobacterial evaluation of 1-(cyclopropyl/2,4-difluorophenyl/tert-butyl)-1,4-dihydro- 8-methyl-6-nitro-4-oxo-7-(substituted secondary amino)quinoline-3-carboxylic acids.
    Senthilkumar P; Dinakaran M; Chandraseakaran Y; Yogeeswari P; Sriram D
    Arch Pharm (Weinheim); 2009 Feb; 342(2):100-12. PubMed ID: 19137533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimycobacterial activity of diphenylpyraline derivatives.
    Weis R; Faist J; di Vora U; Schweiger K; Brandner B; Kungl AJ; Seebacher W
    Eur J Med Chem; 2008 Apr; 43(4):872-9. PubMed ID: 17714832
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A note on the antitubercular activities of 1-aryl-5-benzylsulfanyltetrazoles.
    Adamec J; Waisser K; Kunes J; Kaustová J
    Arch Pharm (Weinheim); 2005 Aug; 338(8):385-9. PubMed ID: 16041837
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Conjugation of a 5-nitrofuran-2-oyl moiety to aminoalkylimidazoles produces non-toxic nitrofurans that are efficacious in vitro and in vivo against multidrug-resistant Mycobacterium tuberculosis.
    Krasavin M; Lukin A; Vedekhina T; Manicheva O; Dogonadze M; Vinogradova T; Zabolotnykh N; Rogacheva E; Kraeva L; Yablonsky P
    Eur J Med Chem; 2018 Sep; 157():1115-1126. PubMed ID: 30179748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of moxifloxacin-acetyl-1,2,3-1H-triazole-methylene-isatin hybrids as potential anti-tubercular agents against both drug-susceptible and drug-resistant Mycobacterium tuberculosis strains.
    Gao F; Chen Z; Ma L; Fan Y; Chen L; Lu G
    Eur J Med Chem; 2019 Oct; 180():648-655. PubMed ID: 31352245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. N-benzylsalicylthioamides: highly active potential antituberculotics.
    Dolezal R; Waisser K; Petrlíková E; Kunes J; Kubicová L; Machácek M; Kaustová J; Dahse HM
    Arch Pharm (Weinheim); 2009 Feb; 342(2):113-9. PubMed ID: 19137534
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rational design and synthesis of novel dibenzo[b,d]furan-1,2,3-triazole conjugates as potent inhibitors of Mycobacterium tuberculosis.
    Yempala T; Sridevi JP; Yogeeswari P; Sriram D; Kantevari S
    Eur J Med Chem; 2014 Jan; 71():160-7. PubMed ID: 24292337
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis and evaluation of in vitro antimycobacterial activity of novel 1H-benzo[d]imidazole derivatives and analogues.
    Gobis K; Foks H; Serocki M; Augustynowicz-Kopeć E; Napiórkowska A
    Eur J Med Chem; 2015 Jan; 89():13-20. PubMed ID: 25462221
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thienopyrimidines as novel inhibitors of Mycobacterium tuberculosis: synthesis and in-vitro studies.
    Rashmi P; Nargund LV; Hazra K; Chandra JN
    Arch Pharm (Weinheim); 2011 Jul; 344(7):459-65. PubMed ID: 21598298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clubbed triazoles: a novel approach to antitubercular drugs.
    Shiradkar M; Suresh Kumar GV; Dasari V; Tatikonda S; Akula KC; Shah R
    Eur J Med Chem; 2007 Jun; 42(6):807-16. PubMed ID: 17239490
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.